Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-04-07 SAHAREK JOHN P. CEO & President, ImprimisRx Shares withheld for taxes −109,475 $23.09 $2.5M 467,388
2025-04-03 SAHAREK JOHN P. CEO & President, ImprimisRx Exercise or conversion +277,200 576,863
2025-04-03 SAHAREK JOHN P. CEO & President, ImprimisRx Exercise or conversion · Performance Stock Unit −277,200 0
2024-09-11 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion +90,000 $7.37 $663K 344,803
2024-09-11 SAHAREK JOHN P. CEO of ImprimisRx Shares withheld for taxes −45,140 $41.37 $1.9M 299,663
2024-09-11 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion · Stock Option (Right to Buy) −90,000 0
2024-03-01 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion +5,000 $8.75 $44K 254,803
2024-03-01 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion · Stock Option (Right to Buy) −5,000 0
2024-02-20 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion +30,000 $10.67 $320K 262,419
2024-02-20 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion −12,616 $10.67 $135K 249,803
2024-02-20 SAHAREK JOHN P. CEO of ImprimisRx Exercise or conversion · RSU −30,000 0
2023-11-10 SAHAREK JOHN P. Chief Commercial Officer Exercise or conversion +20,000 242,197
2023-11-10 SAHAREK JOHN P. Chief Commercial Officer Shares withheld for taxes −9,778 $12.83 $125K 232,419
2023-11-10 SAHAREK JOHN P. Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −20,000 0
2023-07-18 SAHAREK JOHN P. Chief Commercial Officer Exercise or conversion +277,200 331,277
2023-07-18 SAHAREK JOHN P. Chief Commercial Officer Shares withheld for taxes −109,080 $18.23 $2.0M 222,197
2023-07-18 SAHAREK JOHN P. Chief Commercial Officer Exercise or conversion · Performance Stock Unit −277,200 0
2023-04-03 SAHAREK JOHN P. Chief Commercial Officer Grant or award · Restricted Stock Unit +277,200 277,200
2022-02-19 SAHAREK JOHN P. President, ImprimisRx Exercise or conversion +50,000 80,000
2022-02-19 SAHAREK JOHN P. President, ImprimisRx Shares withheld for taxes −25,923 $7.87 $204K 54,077

Page 1 of 2 · 32 trades